Across the nation, not only is marijuana growing more accepted, but so are other drugs like psilocybin and MDMA.

What will 2020 hold for marijuana acceptance, employee misclassification, formularies, and AI?

Testing positive for marijuana use could one day no longer prohibit employment.

With CBD products widely available and advertised for so many ailments, claimants could be using CBD without insurers knowing.

A new white paper explores clinical, legislative, workplace safety, and PBM considerations surrounding marijuana.

Proposed changes to who can grow and research marijuana will soon be available for public commentary.

Beyond exceptions for safety or federal positions, employers cannot refuse employment for testing positive for marijuana in pre-employment drug screenings.

A new study builds upon earlier research with a larger, more up-to-date dataset, finding a reversal in trends.

Though most forms of marijuana are highly regulated, CBD products are readily available across the country. What does this mean for healthcare?

Congress may soon clear federal restrictions to processing marijuana transactions, while the FDA asks for feedback on handling marijuana products.